Keywords: roche, xeloda, effective, adjuvant, therapy, colon, cancer

Roche's Xeloda effective as an adjuvant therapy for colon cancer in Phase III trial

Article | 21 June 2004

Print This

Data reported at the annual meeting of the American Society of Clinical Oncology in New Orleans suggest that Roche's Xeloda ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in